Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1

Author(s):

Maureen P. Martin, Vivek Naranbhai, Patrick R. Shea, Ying Qi, Veron Ramsuran, Nicolas Vince, Xiaojiang Gao, Rasmi Thomas, Zabrina L. Brumme, Jonathan M. Carlson, Steven M. Wolinsky, James J. Goedert, Bruce D. Walker, Florencia P. Segal, Steven G. Deeks, David W. Haas, Stephen A. Migueles, Mark Connors, Nelson Michael, Jacques Fellay, Emma Gostick, Sian Llewellyn-Lacey, David A. Price, Bernard A. Lafont, Phillip Pymm, Philippa M. Saunders, Jacqueline Widjaja, Shu Cheng Wong, Julian P. Vivian, Jamie Rossjohn, Andrew G. Brooks, Mary Carrington

Details:

Journal of Clinical Investigation, Volume 128, Issue 5, 2018-05-01

Article Link: Click here

Affiliations:

• Massachusetts Institute of Technology
• Columbia University
• Monash University
• Brigham and Women's Hospital
• Northwestern University Feinberg School of Medicine
• Cardiff University
• École Polytechnique Fédérale de Lausanne
• National Cancer Institute (NCI)
• Simon Fraser University
• University of KwaZulu-Natal
• Vanderbilt University School of Medicine
• Nantes Université
• National Institute of Allergy and Infectious Diseases (NIAID)
• Microsoft Research
• CHU de Nantes
• Walter Reed Army Institute of Research
• San Francisco General Hospital and Trauma Center
• Leidos Inc.
• Department of Microbiology & Immunology
• HJF
• British Columbia Centre for Excellence in HIV-AIDS
• Centre for the AIDS Programme of Research in South Africa